Frontlight ResearchEarly access
Trial site
AKH - Medizinische Universitat Wien
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Melanoma2 trials
- Ulcerative colitis2 trials
- Alzheimer disease1 trial
- Crohn's disease1 trial
- Gastric and oesophageal cancer1 trial
- Haemophilia1 trial
- Kidney cancer1 trial
- Phase
- Phase 36 trials
- Phase 1/21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Alfasigma S.p.A.2 trials
- Baxalta now part of Shire1 trial
- Biogen1 trial
- Eisai Inc.1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Site data: ClinicalTrials.govUpdated 12 Nov 2026